European Pharmaceutical Review

AUGUST 15, 2023

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. The post CPHI to return to Milan in 2024 appeared first on European Pharmaceutical Review.

Manufacturing 98

Manufacturing Pharma Pharmaceutical Pharmaceutical research 98

PM360

SEPTEMBER 30, 2024

In this issue, we take a closer look at the patient experience and how it is constantly evolving in the pharma industry. From conducting an easier process of scheduling doctors appointments to how patient feedback plays an important role in enhancing the experience, here is what our specialists had to say. It’s the wrong start-point.

Patients 59

Patients Education Doctors Pharmaceutical 59

Clarivate

APRIL 18, 2024

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. More recent developments provide a look into Amazon’s interest in treating patients with chronic conditions, including a pharmacy consultation pilot for high-risk seniors with complex medical needs.

Retail 52

Retail Healthcare Healthcare Physicians 52

Healthcare Success

JANUARY 2, 2024

Now that the holidays have drawn to a close, it’s time to return to your 2024 marketing plan and make adjustments that ensure your business is taking advantage of the latest trends in healthcare marketing to reach patients and HCPs more effectively and make a lasting impression. This helps improve click-through and conversion rates.

Healthcare 78

Healthcare Healthcare Marketing Healthcare Provider 78

PM360

OCTOBER 8, 2024

The high-profile appointment follows the merger of Bioclinica DSS, MyMeds&Me and Commonwealth Informatics under the Qinecsa brand two years ago, and the recent addition of Insife to the group in Q1 2024. It was a great honor to be approached to lead Qinecsa’s next important growth phase.

Leads 52

Leads Safety Biopharma Management 52

LEVO Health

DECEMBER 28, 2023

As we look toward 2024, video marketing is set to become a critical component of a comprehensive marketing strategy. This approach tailors the viewing experience to individual patients, considering their unique needs, preferences, and behaviors. As we look ahead to 2024, AI and machine learning are poised to play an even larger role.

Marketing 52

Marketing Healthcare Healthcare Education 52

Nixon Gwilt Law

NOVEMBER 30, 2023

Reimbursement for Community Health Integration, Social Determinants Risk Assessment, and Principal Illness Navigation On November 2, the Centers for Medicare and Medicaid Services (“CMS”) released the 2024 Medicare Physician Fee Schedule (“2024 MPFS”) final rule.

Physicians 52

Physicians Patients Training Management 52

Nixon Gwilt Law

NOVEMBER 30, 2023

Reimbursement for Community Health Integration, Social Determinants Risk Assessment, and Principal Illness Navigation On November 2, the Centers for Medicare and Medicaid Services (“CMS”) released the 2024 Medicare Physician Fee Schedule (“2024 MPFS”) final rule.

Physicians 52

Physicians Patients Management Training 52

Nixon Gwilt Law

MAY 17, 2024

ATA Nexus 2024: 4 Game-Changing Takeaways for Healthcare Innovators The ATA Nexus 2024 Conference , one of the largest gatherings of virtual healthcare experts and thought leaders, just took place in Phoenix last week. Integrating your data – Healthcare workers are receiving large quantities of data from patients around the clock.

Healthcare 52

Healthcare Healthcare Patients Training 52

Eversana Intouch

SEPTEMBER 27, 2024

With the theme “Shaping the Future of Anticancer Therapies,” ESMO 2024 saw record crowds and focused on advancements across immuno-oncology, antibody drug conjugates (ADCs) and numerous malignancies. And I am on site at ESMO 2024 in sunny Barcelona. EVERSANA was there with teams from across the U.S.

Patients 59

Patients Medical Healthcare Healthcare 59

Penrod

MARCH 7, 2024

Digital patient forms offer a superior solution for the healthcare sector, swiftly supplanting traditional paperwork. The level of detail needed makes the task tedious for most patients. Effective communication is vital when it comes to providing the best patient care. Safeguarding patient data is crucial.

Healthcare 52

Healthcare Healthcare Patients Leads 52

Nixon Gwilt Law

MAY 17, 2024

ATA Nexus 2024: 4 Game-Changing Takeaways for Healthcare Innovators The ATA Nexus 2024 Conference , one of the largest gatherings of virtual healthcare experts and thought leaders, just took place in Phoenix last week. Integrating your data – Healthcare workers are receiving large quantities of data from patients around the clock.

Healthcare 52

Healthcare Healthcare Training Healthcare Provider 52

European Pharmaceutical Review

JULY 29, 2024

The post CHMP meeting highlights – July 2024 appeared first on European Pharmaceutical Review. The treatment is already authorised in the US, Japan, China, South Korea, Hong Kong, and Israel, based on data from the worldwide Phase III Clarity AD study, of which results were published in November 2022.

Medicine 52

Medicine Marketing Leads Pharmaceutical 52

PM360

FEBRUARY 23, 2024

The team worked directly with the MG patient community to build a clean story, then the team embraced an educational yet youthful film style.

Education 52

Education Pharma Leads Marketing 52

PM360

SEPTEMBER 30, 2024

Practices HCPs should follow to ensure patient confidence and success. The need for patient centricity is ubiquitous, yet the patient journey is still daunting for most and impossible for some. Many patients fail to reach an accurate diagnosis for their condition, or if diagnosed, fail to adhere to their prescribed treatment.

Patients 52

Patients Education Insurance Physicians 52

Penrod

MAY 24, 2024

Inefficient Appointment Scheduling An inefficient appointment scheduling system can lead to long wait times, double booking, and limited appointment availability, frustrating your existing and potential patients. These issues can disrupt the flow of your practice, causing dissatisfaction and potentially leading to a loss of patients.

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Patients 52

PM360

JUNE 23, 2023

Press Release Contact: Kayla Walsh Awards Coordinator, PM360 646-300-8114 kayla.walsh@pm360online.com PM360 Now Accepting Entries for 2024 Pharma Choice Awards Call for the Best Healthcare Creative from the Past Year NEW YORK, NY, June 22, 2023 : The 2024 PM360 Pharma Choice Awards are officially open for entries.

Pharma 52

Pharma Marketing Healthcare Healthcare 52

PM360

FEBRUARY 12, 2024

Created by The European Organization for Rare Diseases (EURORDIS) , this globally coordinated event brings together industry stakeholders to advocate for increased access to medical treatment for patients, caregivers, and their families.

Food and Drug Administration 105

Food and Drug Administration Patients Medical Networking 105

PM360

MAY 23, 2024

Amy Patel Director of Analytics Phreesia A Passion for Data that Improves Patient Outcomes Amy Patel, MPH, brings more than 15 years of experience in healthcare data, analytics and market research to her role as Phreesia’s Director of Analytics. Leveraging these data reports, her team can match patients up to the most relevant health content.

Patients 52

Patients Marketing Healthcare Healthcare 52

PM360

MAY 23, 2024

Enter Mike Edwards, who leads the SCEMBLIX brand team at Novartis. Mike strives to ensure all innovative solutions are properly evaluated, advocated for, and considered—on behalf of SCEMBLIX and, ultimately, the patients who could benefit from it.” But, Mike realized there was still work to be done in CML.

Patients 52

Patients Pharma Leads Marketing 52

PM360

OCTOBER 22, 2024

In the pharmaceutical industry, patient support programs (PSPs) and brand teams often work in silos, despite their shared goal of helping patients achieve a certain health outcome. Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcare providers (HCPs).

Patients 59

Patients Healthcare Provider Pharma Prescription 59

European Pharmaceutical Review

JUNE 10, 2024

The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. This news follows the company beginning construction on a similar facility in France , which is set to produce lead-212 radioligand therapies for the European market. billion.

Manufacturing 98

Manufacturing Distribution Pharmaceutical manufacturing Leads 98

Pharmacy Times

JUNE 14, 2024

OTC products are cost-effective and offer patients a convenient self-treatment option.

Leads 26

Leads Patients 26

PM360

MAY 23, 2024

Alex is an integrated marketing strategist with over 13 years of experience leading consumer, healthcare, and medical brands to success. Using human-centered methodologies, he approaches business challenges by collaborating with patients and healthcare professionals to ensure business goals and customer values are aligned.

Specialization 52

Specialization Marketing Healthcare Healthcare 52

Nixon Gwilt Law

JANUARY 16, 2024

What can digital health innovators and investors anticipate for the industry in 2024? What can digital health innovators and investors anticipate for the industry in 2024? Read on to find out what else is on our Legal Vision Board for 2024!

Healthcare 52

Healthcare Healthcare Management Insurance 52

European Pharmaceutical Review

MAY 27, 2024

Repurposing cyclophosphamide may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, new research suggests. The study is assessing patients treated with cyclophosphamide and peripheral blood stem cell (PBSC) transplantation.

Side effects 111

Side effects Leads Patients Pharmaceutical 111

PM360

AUGUST 7, 2024

The Impact of Generative AI on Drug Development, Healthcare, and Patients You can’t swing a bat today without hitting something with “AI” tacked onto it. 1 This lack of representation can lead to skewed data and treatments that may not be as effective for other demographics. Let’s start at the beginning with drug discovery.

Patients 52

Patients Side effects Training Management 52

Nixon Gwilt Law

JANUARY 16, 2024

What can digital health innovators and investors anticipate for the industry in 2024? Read on to find out what else is on our Legal Vision Board for 2024! What started as a drug to help patients with Type 2 diabetes is now the preferred weight loss aid of many celebrities, influencers, and everyday people.

Healthcare 52

Healthcare Healthcare Management Insurance 52

Pharmacy Times

NOVEMBER 17, 2024

Value-based payment models are becoming increasingly common, leading clinicians to find novel ways to engage patients and improve disease control with the goal of reducing morbidity, mortality, and cost.

Management 26

Management Leads Patients 26

PM360

JUNE 24, 2024

In the rapidly evolving global healthcare landscape, the relationship between patients and healthcare professionals (HCPs) remains crucial for effective treatment and care delivery. highlighting the urgent need for improving patient outcomes in the country. highlighting the urgent need for improving patient outcomes in the country.

Physicians 59

Physicians Patients Healthcare Provider Healthcare 59

Legacy MEDSearch

DECEMBER 19, 2022

Chairman, Dave Ferrera, announced treatment of the first patients in North America with the BossStent® device designed to treat patients with symptomatic cerebral venous diseases. Both the EU and FDA clinical trials will be initiated in Q2 2023 for the purpose of obtaining European and US regulatory approvals respectively in Q1 2024.

Patients 98

Patients Recruitment Physicians Management 98

European Pharmaceutical Review

JUNE 13, 2024

Tell us about Ocugen’s lead programme, OCU400. In April 2024, Ocugen received US Food and Drug Administration (FDA) clearance to initiate the Phase III liMeliGhT clinical trial for OCU400 for retinitis pigmentosa. In May 2024, Ocugen announced the second cohort (medium dose) completed dosing in the dose-escalation phase.

Manufacturing 145

Manufacturing Food and Drug Administration Engineering Safety 145

European Pharmaceutical Review

APRIL 17, 2024

Roche’s twice-yearly, 10-minute subcutaneous injection of OCREVUS ® (ocrelizumab) has shown significant promise for patients with either with relapsing or primary progressive multiple sclerosis (RMS or PPMS). percent had no relapse) in patients through 48 weeks of the treatment. No new safety signals were identified for OCREVUS SC.

Food and Drug Administration 93

Food and Drug Administration Safety Medicine Food 93

eMediWrite

DECEMBER 22, 2023

Brand teams that understand the changing nature of marketing and their target audiences have an advantage over their slower-moving competitors, and a growing lead if they have already made changes. Prior to committing to those activities, pharma marketing executives should make certain that their teams: Begin pressing right immediately.

Pharma 52

Pharma Marketing Distribution Leads 52

European Pharmaceutical Review

OCTOBER 29, 2024

Aliada’s lead asset ALIA-1758 is an anti-pyroglutamate amyloid beta (3pE-Aβ) antibody being developed to treat the neurodegenerative disease. This acquisition is set to close in the fourth quarter of 2024, subject to regulatory approvals and other customary closing conditions.

Transportation 59

Transportation Medicine Healthcare Healthcare 59

PM360

MAY 21, 2024

Navigating the complex healthcare system can be a stressful experience for patients, from obtaining a diagnosis to finding the right specialty care or treatment. To help alleviate some of the challenges patients face, it’s crucial to meet them with personalized resources that fit their needs at different stages throughout their journey.

Patients 52

Patients Prescription Side effects Doctors 52

European Pharmaceutical Review

NOVEMBER 21, 2023

Phase III trials of a low carbon version of GSK’s metered dose inhaler, Ventolin (salbutamol), using a next generation, lower carbon propellant, are set to start in 2024. According to GSK, thirty-five million patients with respiratory conditions globally relying on its metered dose inhaler.

Manufacturing 116

Manufacturing Patients Pharma Leads 116